{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:34:21Z","timestamp":1786480461842,"version":"build-2736575974"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.lfs.2026.124581","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:40:01Z","timestamp":1783467601000},"page":"124581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Gut microbiota and metabolites in remodeling the tumor microenvironment and regulating immunotherapeutic efficacy in colorectal cancer"],"prefix":"10.1016","volume":"402","author":[{"given":"Meichen","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuxue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhehao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.lfs.2026.124581_bb0005","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1056\/NEJMoa2400634","article-title":"Neoadjuvant immunotherapy in locally advanced mismatch repair-deficient colon cancer","volume":"390","author":"Chalabi","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.lfs.2026.124581_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2021.04.021","article-title":"Universal immunohistochemistry for Lynch syndrome: a systematic review and meta-analysis of 58,580 colorectal carcinomas","volume":"20","author":"Eikenboom","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.lfs.2026.124581_bb0015","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41591-024-03360-5","article-title":"Neoadjuvant chemoradiation with or without PD-1 blockade in locally advanced rectal cancer: a randomized phase 2 trial","volume":"31","author":"Yang","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2026.124581_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103312","article-title":"Total neoadjuvant therapy integrating long-course radiotherapy with trifluridine\/tipiracil for locally advanced rectal cancer: a single-arm, multicenter phase 2 trial","volume":"85","author":"Dou","year":"2025","journal-title":"EClinicalMedicine"},{"issue":"18","key":"10.1016\/j.lfs.2026.124581_bb0025","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1200\/JCO.19.03296","article-title":"Regorafenib plus nivolumab in patients with advanced gastric or colorectal cancer: an open-label, dose-escalation, and dose-expansion phase Ib trial (REGONIVO, EPOC1603)","volume":"38","author":"Fukuoka","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.lfs.2026.124581_bb0030","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/gutjnl-2015-309800","article-title":"Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer","volume":"66","author":"Yu","year":"2017","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.lfs.2026.124581_bb0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tim.2020.01.001","article-title":"Microbiome in colorectal cancer: how to get from meta-omics to mechanism?","volume":"28","author":"Ternes","year":"2020","journal-title":"Trends Microbiol."},{"issue":"4","key":"10.1016\/j.lfs.2026.124581_bb0040","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00013-22","article-title":"Meta-analysis of altered gut microbiota reveals microbial and metabolic biomarkers for colorectal cancer","volume":"10","author":"Avuthu","year":"2022","journal-title":"Microbiol. Spectr."},{"issue":"1","key":"10.1016\/j.lfs.2026.124581_bb0045","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1186\/s12967-024-05786-4","article-title":"Gut microbial and metabolomics profiles reveal the potential mechanism of fecal microbiota transplantation in modulating the progression of colitis-associated colorectal cancer in mice","volume":"22","author":"Song","year":"2024","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.lfs.2026.124581_bb0050","article-title":"Multi-omics of the gut microbial ecosystem in patients with microsatellite-instability-high gastrointestinal cancer resistant to immunotherapy","volume":"5","author":"Cheng","year":"2024","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.lfs.2026.124581_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.993285","article-title":"Gut microbiota distinct between colorectal cancers with deficient and proficient mismatch repair: a study of 230 CRC patients","volume":"13","author":"Jin","year":"2022","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.lfs.2026.124581_bb0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3945\/ajcn.112.056689","article-title":"Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans","volume":"98","author":"Ou","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"issue":"5","key":"10.1016\/j.lfs.2026.124581_bb0065","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s42255-024-01037-4","article-title":"Acetate reprogrammes tumour metabolism and promotes PD-L1 expression and immune evasion by upregulating c-Myc","volume":"6","author":"Wang","year":"2024","journal-title":"Nat. Metab."},{"issue":"8","key":"10.1016\/j.lfs.2026.124581_bb0070","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","article-title":"Short-chain fatty acids: linking diet, the microbiome and immunity","volume":"24","author":"Mann","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.lfs.2026.124581_bb0075","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1136\/gutjnl-2023-330291","article-title":"Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8(+) T cells","volume":"72","author":"Kang","year":"2023","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.lfs.2026.124581_bb0080","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/s43018-023-00636-6","article-title":"Acetate acts as a metabolic immunomodulator by bolstering T-cell effector function and potentiating antitumor immunity in breast cancer","volume":"4","author":"Miller","year":"2023","journal-title":"Nat. Cancer"},{"issue":"2","key":"10.1016\/j.lfs.2026.124581_bb0085","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cmet.2025.01.005","article-title":"The emerging role of dysregulated propionate metabolism and methylmalonic acid in metabolic disease, aging, and cancer","volume":"37","author":"Shafer","year":"2025","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.lfs.2026.124581_bb0090","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/ijc.33725","article-title":"Circulating tryptophan metabolites and risk of colon cancer: results from case-control and prospective cohort studies","volume":"149","author":"Papadimitriou","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.lfs.2026.124581_bb0095","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.cmet.2023.04.015","article-title":"Lactobacillus plantarum-derived indole-3-lactic acid ameliorates colorectal tumorigenesis via epigenetic regulation of CD8(+) T cell immunity","volume":"35","author":"Zhang","year":"2023","journal-title":"Cell Metab."},{"issue":"7","key":"10.1016\/j.lfs.2026.124581_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.02.022","article-title":"Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer","volume":"187","author":"Jia","year":"2024","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.lfs.2026.124581_bb0105","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1136\/gutjnl-2023-329543","article-title":"Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1\/Kyn\/AHR axis","volume":"72","author":"Fong","year":"2023","journal-title":"Gut"},{"issue":"14","key":"10.1016\/j.lfs.2026.124581_bb0110","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.7150\/ijbs.85712","article-title":"Akkermansia muciniphila inhibits tryptophan metabolism via the AhR\/\u03b2-catenin signaling pathway to counter the progression of colorectal cancer","volume":"19","author":"Zhang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2026.124581_bb0115","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41556-023-01314-6","article-title":"Gut microbial metabolite facilitates colorectal cancer development via ferroptosis inhibition","volume":"26","author":"Cui","year":"2024","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.lfs.2026.124581_bb0120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","article-title":"Bile acids and the gut microbiota: metabolic interactions and impacts on disease","volume":"21","author":"Collins","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.lfs.2026.124581_bb0125","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","article-title":"Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis","volume":"30","author":"Cai","year":"2022","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.lfs.2026.124581_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2024.02.014","article-title":"Bile acids modified by the intestinal microbiota promote colorectal cancer growth by suppressing CD8(+) T cell effector functions","volume":"57","author":"Cong","year":"2024","journal-title":"Immunity"},{"issue":"6510","key":"10.1016\/j.lfs.2026.124581_bb0135","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.abc3421","article-title":"Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy","volume":"369","author":"Mager","year":"2020","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.lfs.2026.124581_bb0140","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004037","article-title":"Gallic acid induces T-helper-1-like T(reg) cells and strengthens immune checkpoint blockade efficacy","volume":"10","author":"Deng","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.lfs.2026.124581_bb0145","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1089\/ars.2014.5933","article-title":"The therapeutic potential of cystathionine \u03b2-synthetase\/hydrogen sulfide inhibition in cancer","volume":"22","author":"Hellmich","year":"2015","journal-title":"Antioxid. Redox Signal."},{"issue":"11","key":"10.1016\/j.lfs.2026.124581_bb0150","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/s41575-019-0209-8","article-title":"Gut microbiota in colorectal cancer: mechanisms of action and clinical applications","volume":"16","author":"Wong","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2026.124581_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113778","article-title":"Toll-like receptor 4 deficiency alleviates lipopolysaccharide-induced intestinal barrier dysfunction","volume":"155","author":"Zhan","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.lfs.2026.124581_bb0160","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.cell.2017.07.018","article-title":"Drugs, bugs, and cancer: Fusobacterium nucleatum promotes Chemoresistance in colorectal cancer","volume":"170","author":"Ramos","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.lfs.2026.124581_bb0165","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s41564-025-01938-4","article-title":"Dietary fibre counters the oncogenic potential of colibactin-producing Escherichia coli in colorectal cancer","volume":"10","author":"Thakur","year":"2025","journal-title":"Nat. Microbiol."},{"issue":"1","key":"10.1016\/j.lfs.2026.124581_bb0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13073-024-01344-1","article-title":"Colorectal cancer microbiome programs DNA methylation of host cells by affecting methyl donor metabolism","volume":"16","author":"Liu","year":"2024","journal-title":"Genome Med."},{"issue":"5","key":"10.1016\/j.lfs.2026.124581_bb0175","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1158\/0008-5472.CAN-13-1865","article-title":"Fusobacterium in colonic flora and molecular features of colorectal carcinoma","volume":"74","author":"Tahara","year":"2014","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.lfs.2026.124581_bb0180","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cmi.2024.01.013","article-title":"Enrichment of Bacteroides fragilis and enterotoxigenic Bacteroides fragilis in CpG island methylator phenotype-high colorectal carcinoma","volume":"30","author":"Takashima","year":"2024","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.lfs.2026.124581_bb0185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12934-017-0691-z","article-title":"Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria","volume":"16","author":"LeBlanc","year":"2017","journal-title":"Microb. Cell Fact."},{"issue":"1","key":"10.1016\/j.lfs.2026.124581_bb0190","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s40168-020-00847-4","article-title":"Bacteria pathogens drive host colonic epithelial cell promoter hypermethylation of tumor suppressor genes in colorectal cancer","volume":"8","author":"Xia","year":"2020","journal-title":"Microbiome"},{"issue":"2","key":"10.1016\/j.lfs.2026.124581_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2017.06.008","article-title":"Nuclear acetyl-CoA production by ACLY promotes homologous recombination","volume":"67","author":"Sivanand","year":"2017","journal-title":"Mol. Cell"},{"issue":"7827","key":"10.1016\/j.lfs.2026.124581_bb0200","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41586-020-2604-2","article-title":"Microbiota-derived metabolite promotes HDAC3 activity in the gut","volume":"586","author":"Wu","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.lfs.2026.124581_bb0205","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s42255-024-01191-9","article-title":"Short-chain fatty acid metabolites propionate and butyrate are unique epigenetic regulatory elements linking diet, metabolism and gene expression","volume":"7","author":"Nshanian","year":"2025","journal-title":"Nat. Metab."},{"issue":"1","key":"10.1016\/j.lfs.2026.124581_bb0210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.chom.2015.12.005","article-title":"The host shapes the gut microbiota via fecal microRNA","volume":"19","author":"Liu","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.lfs.2026.124581_bb0215","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1038\/s41598-020-65207-6","article-title":"Exosomal miR-21 promotes proliferation, invasion and therapy resistance of colon adenocarcinoma cells through its target PDCD4","volume":"10","author":"Sun","year":"2020","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.lfs.2026.124581_bb0220","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41388-021-02084-x","article-title":"MiR-138 is a potent regulator of the heterogenous MYC transcript population in cancers","volume":"41","author":"Desi","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2026.124581_bb0225","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12943-015-0450-x","article-title":"Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells","volume":"14","author":"Hu","year":"2015","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.lfs.2026.124581_bb0230","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03928-24","article-title":"Human-derived microRNA 21 regulates indole and L-tryptophan biosynthesis transcripts in the gut commensal Bacteroides thetaiotaomicron","volume":"16","author":"Flanagan","year":"2025","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.lfs.2026.124581_bb0235","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","article-title":"Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.lfs.2026.124581_bb0240","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/s41423-025-01326-2","article-title":"The gut microbiota in cancer immunity and immunotherapy","volume":"22","author":"Xie","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"9","key":"10.1016\/j.lfs.2026.124581_bb0245","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.7150\/thno.54476","article-title":"Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"issue":"7683","key":"10.1016\/j.lfs.2026.124581_bb0250","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature24673","article-title":"Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth","volume":"552","author":"Germano","year":"2017","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.lfs.2026.124581_bb0255","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2026.124581_bb0260","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13073-018-0586-6","article-title":"Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers","volume":"10","author":"Hale","year":"2018","journal-title":"Genome Med."},{"issue":"8","key":"10.1016\/j.lfs.2026.124581_bb0265","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007420","article-title":"Depicting the landscape of gut microbial-metabolic interaction and microbial-host immune heterogeneity in deficient and proficient DNA mismatch repair colorectal cancers","volume":"11","author":"Li","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"12","key":"10.1016\/j.lfs.2026.124581_bb0270","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41571-024-00943-6","article-title":"Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response","volume":"21","author":"Williams","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.lfs.2026.124581_bb0275","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41522-025-00818-3","article-title":"Harnessing gut microbiota for colorectal cancer therapy: from clinical insights to therapeutic innovations","volume":"11","author":"Chen","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"8078","key":"10.1016\/j.lfs.2026.124581_bb0280","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/s41586-025-09249-8","article-title":"Microbiota-driven antitumour immunity mediated by dendritic cell migration","volume":"644","author":"Lin","year":"2025","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.lfs.2026.124581_bb0285","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s00262-024-03665-x","article-title":"Bifidobacterium modulation of tumor immunotherapy and its mechanism","volume":"73","author":"Pei","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"issue":"44","key":"10.1016\/j.lfs.2026.124581_bb0290","doi-asserted-by":"crossref","first-page":"27509","DOI":"10.1073\/pnas.1921223117","article-title":"Bifidobacterium alters the gut microbiota and modulates the functional metabolism of T regulatory cells in the context of immune checkpoint blockade","volume":"117","author":"Sun","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.lfs.2026.124581_bb0295","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.cell.2023.03.011","article-title":"Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment","volume":"186","author":"Bender","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2026.124581_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104533","article-title":"Lacticaseibacillus rhamnosus Probio-M9 enhanced the antitumor response to anti-PD-1 therapy by modulating intestinal metabolites","volume":"91","author":"Gao","year":"2023","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.lfs.2026.124581_bb0305","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1136\/gutjnl-2022-327853","article-title":"Acetyltransferase from Akkermansia muciniphila blunts colorectal tumourigenesis by reprogramming tumour microenvironment","volume":"72","author":"Jiang","year":"2023","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.lfs.2026.124581_bb0310","doi-asserted-by":"crossref","first-page":"e70540","DOI":"10.1096\/fj.202403295RR","article-title":"Amuc_1434 from Akkermansia muciniphila enhances CD8+ T cell-mediated anti-tumor immunity by suppressing PD-L1 in colorectal cancer","volume":"39","author":"Zhu","year":"2025","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.lfs.2026.124581_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114306","article-title":"Landscape of tumoral ecosystem for enhanced anti-PD-1 immunotherapy by gut Akkermansia muciniphila","volume":"43","author":"Zhu","year":"2024","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.lfs.2026.124581_bb0320","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1038\/s41564-019-0541-3","article-title":"Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity","volume":"4","author":"Long","year":"2019","journal-title":"Nat. Microbiol."},{"issue":"6","key":"10.1016\/j.lfs.2026.124581_bb0325","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/s41564-024-01695-w","article-title":"Peptostreptococcus anaerobius mediates anti-PD1 therapy resistance and exacerbates colorectal cancer via myeloid-derived suppressor cells in mice","volume":"9","author":"Liu","year":"2024","journal-title":"Nat. Microbiol."},{"issue":"1","key":"10.1016\/j.lfs.2026.124581_bb0330","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2320291","article-title":"The colibactin-producing Escherichia coli alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistance","volume":"16","author":"de Oliveira Alves","year":"2024","journal-title":"Gut Microbes"},{"issue":"2","key":"10.1016\/j.lfs.2026.124581_bb0335","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ni.1828","article-title":"Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21","volume":"11","author":"Sheedy","year":"2010","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.lfs.2026.124581_bb0340","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.chom.2023.04.010","article-title":"Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer","volume":"31","author":"Jiang","year":"2023","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.lfs.2026.124581_bb0345","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41392-021-00795-x","article-title":"Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer","volume":"6","author":"Gao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10","key":"10.1016\/j.lfs.2026.124581_bb0350","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.ccell.2024.08.019","article-title":"Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer","volume":"42","author":"Wang","year":"2024","journal-title":"Cancer Cell"},{"issue":"7826","key":"10.1016\/j.lfs.2026.124581_bb0355","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41586-020-2729-3","article-title":"Host-microbiota maladaptation in colorectal cancer","volume":"585","author":"Janney","year":"2020","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.lfs.2026.124581_bb0360","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1158\/2159-8290.CD-20-0770","article-title":"Bacterial-driven inflammation and mutant BRAF expression combine to promote murine colon tumorigenesis that is sensitive to immune checkpoint therapy","volume":"11","author":"DeStefano Shields","year":"2021","journal-title":"Cancer Discov."},{"issue":"6264","key":"10.1016\/j.lfs.2026.124581_bb0365","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"V\u00e9tizou","year":"2015","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.lfs.2026.124581_bb0370","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41591-024-02803-3","article-title":"Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma","volume":"30","author":"Bj\u00f6rk","year":"2024","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.lfs.2026.124581_bb0375","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41392-023-01693-0","article-title":"Intratumoural microbiota: a new frontier in cancer development and therapy","volume":"9","author":"Cao","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.lfs.2026.124581_bb0380","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1578861","article-title":"Comparative microbiome analysis of paired mucosal and fecal samples in Korean colorectal cancer patients","volume":"15","author":"Kim","year":"2025","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.lfs.2026.124581_bb0385","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41591-024-02823-z","article-title":"A gut microbial signature for combination immune checkpoint blockade across cancer types","volume":"30","author":"Gunjur","year":"2024","journal-title":"Nat. Med."},{"issue":"6575","key":"10.1016\/j.lfs.2026.124581_bb0390","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1126\/science.aaz7015","article-title":"Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response","volume":"374","author":"Spencer","year":"2021","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.lfs.2026.124581_bb0395","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.cell.2020.04.027","article-title":"Ketogenic diets alter the gut microbiome resulting in decreased intestinal Th17 cells","volume":"181","author":"Ang","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.lfs.2026.124581_bb0400","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/2159-8290.CD-21-0030","article-title":"Fasting-mimicking diet is safe and reshapes metabolism and antitumor immunity in patients with cancer","volume":"12","author":"Vernieri","year":"2022","journal-title":"Cancer Discov."},{"issue":"5","key":"10.1016\/j.lfs.2026.124581_bb0405","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/gutjnl-2024-333020","article-title":"Fasting-mimicking diet-enriched Bifidobacterium pseudolongum suppresses colorectal cancer by inducing memory CD8(+) T cells","volume":"74","author":"Nan","year":"2025","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.lfs.2026.124581_bb0410","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1136\/gutjnl-2020-321031","article-title":"Ginseng polysaccharides alter the gut microbiota and kynurenine\/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1\/programmed cell death ligand 1 (anti-PD-1\/PD-L1) immunotherapy","volume":"71","author":"Huang","year":"2022","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.lfs.2026.124581_bb0415","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1039\/D3FO04807A","article-title":"Fucoidan enhances the anti-tumor effect of anti-PD-1 immunotherapy by regulating gut microbiota","volume":"15","author":"Li","year":"2024","journal-title":"Food Funct."},{"issue":"6","key":"10.1016\/j.lfs.2026.124581_bb0420","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41419-019-1638-6","article-title":"Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment","volume":"10","author":"Lv","year":"2019","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.lfs.2026.124581_bb0425","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ajg.2013.4","article-title":"Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections","volume":"108","author":"Surawicz","year":"2013","journal-title":"Am. J. Gastroenterol."},{"issue":"6529","key":"10.1016\/j.lfs.2026.124581_bb0430","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"issue":"6529","key":"10.1016\/j.lfs.2026.124581_bb0435","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.lfs.2026.124581_bb0440","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1038\/s41467-020-16602-0","article-title":"Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity","volume":"11","author":"Leventhal","year":"2020","journal-title":"Nat. Commun."},{"issue":"530","key":"10.1016\/j.lfs.2026.124581_bb0445","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax0876","article-title":"Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies","volume":"12","author":"Gurbatri","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lfs.2026.124581_bb0450","article-title":"Low-dose intestinal irradiation enhances the efficacy and prognosis of PD-1 blockade in metastatic non-small cell lung cancer","author":"Huang","year":"2026","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.lfs.2026.124581_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2025.02.010","article-title":"Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients","volume":"43","author":"Chen","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lfs.2026.124581_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102315","article-title":"Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215)","volume":"66","author":"Zhao","year":"2023","journal-title":"EClinicalMedicine"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526003905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526003905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:24:33Z","timestamp":1786479873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320526003905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":92,"alternative-id":["S0024320526003905"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124581","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiota and metabolites in remodeling the tumor microenvironment and regulating immunotherapeutic efficacy in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124581","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124581"}}